First Light Diagnostics Closes $8.25 Million Series A-2 Financing

17Jan

First Light Diagnostics Closes $8.25 Million Series A-2 Financing

Portfolio News
First Light Diagnostics, a developer of breakthrough automated products for rapid, sensitive, and cost-effective diagnosis of life-threatening, antibiotic-resistant infections, today announced it has closed an oversubscribed $8.25 million Series A-2 financing. Read more >>

Share this post

Related Posts

19Jul

Philips expands its patient management solutions in the US with the acquisition of Medumo

Royal Philips, a global leader in health technology, today announced that it has expanded its patient management solutions in the... read more
29Jan

RetroSense founder Sean Ainsworth named CEO of Seattle biotech

Sean Ainsworth hopes to strike biotech gold, again, joining Seattle-based Immusoft Corp. as CEO and chairman. Read more >> read more
09Jun

RevBio is Awarded a $2 Million Grant to Advance the Development of its Novel Dental Adhesive Bone Scaffold Product

RevBio, Inc., announced that it has been awarded a $2 million Phase II Small Business Innovation Research (SBIR) grant from... read more
01Dec

Myomo, Inc. Announces Pricing of Public Offering

Myomo, Inc. (NYSE American: MYO), a commercial stage medical robotics company, today announced that it has priced an underwritten public... read more
23Mar

Respiratory Motion, Inc. is excited to announce FDA clearance for use of the ExSpiron™ 1Xi Minute Ventilation Monitor in Pediatric Patients

Respiratory Motion, Inc. reported today that FDA clearance was received for the newest version of its ExSpiron Minute Ventilation (MV)... read more
26Dec

Shares Bringing Holiday Cheer For Investors: Corbus Pharmaceuticals Holdings, Inc.

Shares of Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) have climbed in the previous month. During that time period, shares are up... read more
16Sep

Myomo Certified as Medicare Provider

Myomo, Inc., a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis,... read more
09Jun

Helping a child see for the first time

"She went from, I would say her name and she would look right at to me to just looking around,... read more
13Nov

Corbus Pharmaceuticals to Present at the Jefferies Virtual London Healthcare Conference

Corbus Pharmaceuticals Holdings, Inc., a clinical-stage drug development company pioneering transformative medicines that target the endocannabinoid system, today announced that... read more
24Feb

Not Your Typical Wine Club: Archer Roose Promises Live Snakes as Perks for Customer Loyalty

The premium brand quickly backtracked, admitting it was all a prank in a cheeky campaign starring co-owner and CCO Elizabeth... read more